Dysregulation at any level can lead to disease. For instance, mutations in genes regulating cell cycle checkpoints can result in uncontrolled cell division, leading to cancer. Similarly, aberrant ECM remodeling can contribute to fibrosis, a condition characterized by excessive connective tissue formation. Understanding these regulatory complexities is crucial for developing targeted therapies.
